Drug Shortage Report for MAXIDEX
Report ID | 59391 |
Drug Identification Number | 00042579 |
Brand name | MAXIDEX |
Common or Proper name | MAXIDEX OINTMENT 3.5MG |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | DEXAMETHASONE |
Strength(s) | 0.1% |
Dosage form(s) | OINTMENT |
Route of administration | OPHTHALMIC |
Packaging size | 3.5MG |
ATC code | S01BA |
ATC description | ANTIINFLAMMATORY AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-09-10 |
Actual start date | 2018-09-10 |
Estimated end date | 2019-02-04 |
Actual end date | 2019-02-04 |
Shortage status | Resolved |
Updated date | 2019-02-05 |
Company comments | Maxidex 0.1% Suspension 5ml is available (#742021) |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v33 | 2019-02-05 | English | Compare |
v32 | 2019-02-04 | French | Compare |
v31 | 2019-02-04 | English | Compare |
v30 | 2019-02-01 | French | Compare |
v29 | 2019-02-01 | English | Compare |
v28 | 2019-01-30 | French | Compare |
v27 | 2019-01-30 | English | Compare |
v26 | 2019-01-25 | French | Compare |
v25 | 2019-01-25 | English | Compare |
v24 | 2019-01-09 | French | Compare |
v23 | 2019-01-09 | English | Compare |
v22 | 2018-11-23 | French | Compare |
v21 | 2018-11-23 | English | Compare |
v20 | 2018-11-16 | French | Compare |
v19 | 2018-11-16 | English | Compare |
v18 | 2018-11-01 | French | Compare |
v17 | 2018-11-01 | English | Compare |
v16 | 2018-10-23 | French | Compare |
v15 | 2018-10-23 | English | Compare |
v14 | 2018-10-17 | French | Compare |